Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4321 (MIR4321)
- Target
- MIR4321
- Molecular classification
- Non-coding RNA, MicroRNA
01
Overview
MicroRNA 4321 (MIR4321) is a small, non-coding RNA gene located on human chromosome 19 that encodes a predicted microRNA involved in the post-transcriptional regulation of gene expression[6][7]. Like other microRNAs, MIR4321 is transcribed and processed to produce a short, mature miRNA which may bind to messenger RNAs, typically resulting in downregulation of target gene expression through translational inhibition or mRNA destabilization[7]. The precise cellular functions, validated mRNA targets, and role in human physiology or disease for MIR4321 remain unknown[6][7]. There is currently no evidence that MIR4321 is a therapeutic target, nor are any biomarkers, safety concerns, or interacting drugs reported for this gene. It is classified as a microRNA based on sequence and biogenesis criteria, but function and clinical relevance are yet to be elucidated.
- Other names
- hsa-mir-4321MIR4321
02
Mechanism of action
Not applicable (no known drugs, and function is unclear)
03
Biological functions
Regulation of gene expression (post-transcriptional)Potential involvement in various cellular processes (precise functions currently unknown)
04
Disease associations
Persistent Mullerian Duct Syndrome (based on limited disease associations; evidence for direct functional relevance is weak and may be based on genomic proximity rather than mechanistic insight)Other (due to the typical roles of miRNAs in disease, though no roles are specifically attributed to miR-4321 as of now)
Beyond the preview
Go deeper on MicroRNA 4321 (MIR4321).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroRNA 4321 (MIR4321).